Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 3 Other hematologic neoplasm 3 Lymphoid 3 Gastrointestinal 3 Breast 3 Other solid neoplasm 2 Plasma cell 1 Gynecologic 1 Genitourinary 1 Dermatologic 1

Conditions

Melanoma 1 Carcinoma, Merkel Cell 1

Interventions

pembrolizumab 69 Nivolumab 57 Ipilimumab 36 Specimen Handling 32 Magnetic Resonance Spectroscopy 25 Cyclophosphamide 23 Biopsy 18 cemiplimab 14 fludarabine 13 relatlimab 11 binimetinib 11 Opdualag 11 CTLA-4 Antigen 11 trametinib 10 fludarabine phosphate 10 Radiosurgery 10 avelumab 9 Radiotherapy 9 lifileucel 8 dabrafenib 8 Blood Specimen Collection 8 atezolizumab 7 aldesleukin 7 Paclitaxel 7 encorafenib 6 X-Rays 6 Standard of Care 6 Interleukin-2 6 Immunoglobulin G 6 HhAntag691 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Exercise Test × Dermatologic × 90 days × Clear all

NCT06008977 2026-03-25

EX-BOOST

AdventHealth Translational Research Institute

Phase NA Active not recruiting

Melanoma, Carcinoma, Merkel Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡